Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIWI: Ivacaftor in children 2-5 years with CF
NCT01705145Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jan 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ivacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Jan 2013; status: completed.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01705145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705145.